AI assistant
SOLIGENIX, INC. — Investor Presentation 2014
Sep 8, 2014
35119_rns_2014-09-08_fcfade8c-e90e-4996-b3c6-a94a67c38de0.zip
Investor Presentation
Open in viewerOpens in your device viewer
8-K 1 f8k090814_soligenix.htm CURRENT REPORT
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): September 8, 2014
Commission File No. 000-16929
Soligenix, Inc.
(Exact name of small business issuer as specified in its charter)
| DELAWARE | 41-1505029 |
|---|---|
| (State or | |
| other jurisdiction of incorporation or organization) | (I.R.S. Employer |
| Identification Number) | |
| 29 | |
| Emmons Drive, Suite | |
| C-10 Princeton, | |
| NJ | 08540 |
| (Address of | |
| principal executive offices) | (Zip Code) |
| (609) 538-8200 |
|---|
| (Issuer’s telephone number, including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
Item 7.01 Regulation FD Disclosure.
Soligenix, Inc. (the “Company”) has updated its corporate presentation as of September 8, 2014. The slides from this presentation are attached hereto as Exhibit 99.1. The attached materials will be presented on September 9, 2014 by the Company’s President and Chief Executive Officer, Christopher J. Schaber, PhD., at the 16th Annual Rodman & Renshaw Global Investment Conference and also will be posted on the Company’s website at www.soligenix.com. The Company does not undertake to update this presentation.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description |
|---|---|
| 99.1 | Corporate Presentation. |
Field: Page; Sequence: 2
2
Field: /Page
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| /s/
Christopher J. Schaber |
| --- |
| Christopher
J. Schaber, Ph.D. |
| President
and Chief Executive Officer |
| (Principal
Executive Officer) |
Field: Page; Sequence: 3
3
Field: /Page
EXHIBIT INDEX
| Exhibit
No. | Description |
| --- | --- |
| 99.1 | Corporate Presentation. |
4
Field: Rule-Page
Field: /Rule-Page